Pegylated liposomal doxorubicin-efficacy
β
Peter Hau; Klaus Fabel; Ulrike Baumgart; Petra RΓΌmmele; Oliver Grauer; Annekatri
π
Article
π
2004
π
John Wiley and Sons
π
English
β 215 KB
## Abstract ## BACKGROUND Doxorubicin exhibits high efficacy in malignant glioma cell cultures. Nonetheless, as a standard formulation, doxorubicin has not been used clinically, due to poor penetration of the bloodβbrain barrier. Furthermore, doxorubicin is known to induce tumor resistance genes.